It should be suspected in people with multiple CM, one of POT1-TPD core cancers (CM, CLL, angiosarcoma or glioma) and a first- or second-degree relative with a confirmed POT1-PTD cancer, or a somatic POT1 PV identified on tumour tissue sequencing [1]. This evidence concerns the gene POT1 and Bjornstad syndrome.